214 related articles for article (PubMed ID: 12432954)
1. Reporter gene regulation in Saccharomyces cerevisiae by the human p53 tumor suppressor protein.
Bitter GA; Schaeffer TN; Ellison AR
J Mol Microbiol Biotechnol; 2002 Nov; 4(6):539-50. PubMed ID: 12432954
[TBL] [Abstract][Full Text] [Related]
2. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
3. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
4. p53 mutants exhibiting enhanced transcriptional activation and altered promoter selectivity are revealed using a sensitive, yeast-based functional assay.
Inga A; Monti P; Fronza G; Darden T; Resnick MA
Oncogene; 2001 Jan; 20(4):501-13. PubMed ID: 11313981
[TBL] [Abstract][Full Text] [Related]
5. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.
Di Como CJ; Prives C
Oncogene; 1998 May; 16(19):2527-39. PubMed ID: 9627118
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of the one-carbon metabolism regulon in Saccharomyces cerevisiae by Bas1p.
Subramanian M; Qiao WB; Khanam N; Wilkins O; Der SD; Lalich JD; Bognar AL
Mol Microbiol; 2005 Jul; 57(1):53-69. PubMed ID: 15948949
[TBL] [Abstract][Full Text] [Related]
7. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional properties of feline p53 and its tumour-associated mutants: a yeast-based approach.
Cardellino U; Ciribilli Y; Andreotti V; Modesto P; Menichini P; Fronza G; Pellegrino C; Inga A
Mutagenesis; 2007 Nov; 22(6):417-23. PubMed ID: 17947339
[TBL] [Abstract][Full Text] [Related]
9. Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.
Kim E; Rohaly G; Heinrichs S; Gimnopoulos D; Meissner H; Deppert W
Oncogene; 1999 Dec; 18(51):7310-8. PubMed ID: 10602486
[TBL] [Abstract][Full Text] [Related]
10. The human p53 negative regulatory domain mediates inhibition of reporter gene transactivation in yeast lacking thioredoxin reductase.
Merrill GF; Dowell P; Pearson GD
Cancer Res; 1999 Jul; 59(13):3175-9. PubMed ID: 10397262
[TBL] [Abstract][Full Text] [Related]
11. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
12. CP-31398, a putative p53-stabilizing molecule tested in mammalian cells and in yeast for its effects on p53 transcriptional activity.
Tanner S; Barberis A
J Negat Results Biomed; 2004 Nov; 3():5. PubMed ID: 15548325
[TBL] [Abstract][Full Text] [Related]
13. Molecular evidence for a positive role of Spt4 in transcription elongation.
Rondón AG; García-Rubio M; González-Barrera S; Aguilera A
EMBO J; 2003 Feb; 22(3):612-20. PubMed ID: 12554661
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of p53 enhances transcription-coupled repair and global genomic repair of a UVC-damaged reporter gene in human cells.
Dregoesc D; Rybak AP; Rainbow AJ
DNA Repair (Amst); 2007 May; 6(5):588-601. PubMed ID: 17196445
[TBL] [Abstract][Full Text] [Related]
15. A novel p53 mutational hotspot in skin tumors from UV-irradiated Xpc mutant mice alters transactivation functions.
Inga A; Nahari D; Velasco-Miguel S; Friedberg EC; Resnick MA
Oncogene; 2002 Aug; 21(37):5704-15. PubMed ID: 12173040
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor p53 associates with gene coding regions and co-traverses with elongating RNA polymerase II in an in vivo model.
Balakrishnan SK; Gross DS
Oncogene; 2008 Apr; 27(19):2661-72. PubMed ID: 18026140
[TBL] [Abstract][Full Text] [Related]
17. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.
Kichina JV; Rauth S; Das Gupta TK; Gudkov AV
Oncogene; 2003 Jul; 22(31):4911-7. PubMed ID: 12894234
[TBL] [Abstract][Full Text] [Related]
18. Human p53 induces cell death and downregulates thioredoxin expression in Saccharomyces cerevisiae.
Hadj Amor IY; Smaoui K; Chaabène I; Mabrouk I; Djemal L; Elleuch H; Allouche M; Mokdad-Gargouri R; Gargouri A
FEMS Yeast Res; 2008 Dec; 8(8):1254-62. PubMed ID: 19054132
[TBL] [Abstract][Full Text] [Related]
19. Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.
Smardová J; Pavlová S; Svitáková M; Grochová D; Ravcuková B
Oncol Rep; 2005 Oct; 14(4):901-7. PubMed ID: 16142349
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin upregulates Saccharomyces cerevisiae genes involved in iron homeostasis through activation of the iron insufficiency-responsive transcription factor Aft1.
Kimura A; Ohashi K; Naganuma A
J Cell Physiol; 2007 Feb; 210(2):378-84. PubMed ID: 17096368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]